The research promises to be the first exploration of naturalistic psilocybin microdosing in a lab-setting using a cutting-edge neuroimaging technique and a unique kind of trial protocol.
Storyboard
Microdosing mysteries: The new science exploring tiny doses of psychedelics
For years people have anecdotally espoused the benefits of microdosing psychedelics, from improving mental health to enhancing creativity. But only recently have scientists begun to empirically explore the common practice and start to work out whether microdose really works or whether it is a massive placebo effect.
A first-of-its-kind trial testing the pain-killing properties of LSD microdoses is suggesting tiny, non-psychedelic doses of this infamous drug could serve as an effective analgesic.
The results of the small trial suggest minute doses of THC may confer clinically apparent reductions in pain sensation without inducing psychoactive side effects.
“The study provides reassuring safety data and opens the door for larger scale clinical trials to evaluate the potential therapeutic effects of LSD.”
The company claims the product is ready and waiting for legalization measures in the United States to pass over the coming years.
Denver-based company Sträva Craft Coffee has revealed it has begun developing tea and coffee products infused with microdoses of psilocybin.
Scientists at the University of Chicago are offering the very first placebo-controlled clinical research testing the mood-altering, physiological and behavioral effects of LSD microdoses.
The results yielded a variety of unexpected effects including some surprising negative changes affirming the need for more research into this growing trend.
A fascinating observational, longitudinal study tracking the experiences of nearly 100 microdosing subjects over six weeks.
Storyboard
